E-LIB Suche - Ergebnisse für: Hart, T K

1

The IQ DruSafe nonclinical to clinical translational databa..:

Monticello, T.M. ; Jones, T.W. ; Dambach, D.M....
Toxicology Letters. 258 (2016) - p. S133 , 2016

Link: https://doi.org/10.1016/..

2

Preclinical efficacy and safety of pascolizumab (SB 240683)..:

HART, T K ; BLACKBURN, M N ; BRIGHAM-BURKE, M...
Clinical and Experimental Immunology. 130 (2002) 1 - p. 93-100 , 2002

Link: https://doi.org/10.1046/..

3

Practical aspects of including functional endpoints in deve..:

Herzyk, D J ; Bugelski, P J ; Hart, T K.
Human & Experimental Toxicology. 21 (2002) 9-10 - p. 507-512 , 2002

Link: https://doi.org/10.1191/..

4

Preclinical development of keliximab, a Primatized™ anti-CD..:

Bugelskil, P J ; Herzykl, D J ; Rehm, S...
Human & Experimental Toxicology. 19 (2000) 4 - p. 230-243 , 2000

Link: https://doi.org/10.1191/..

5

Safety evaluation of immunomodulatory biopharmaceuticals: c..:

Black, L E ; Green, J D ; Rener, J...
Human & Experimental Toxicology. 19 (2000) 4 - p. 205-207 , 2000

Link: https://doi.org/10.1191/..

6

Effect of SB 217242 on Hypoxia-Induced Cardiopulmonary Chan..:

Underwood, D.C. ; Bochnowicz, S. ; Osborn, R.R....
Pulmonary Pharmacology & Therapeutics. 12 (1999) 1 - p. 13-26 , 1999

Link: https://doi.org/10.1006/..

7

Morphometric analysis of envelope glycoprotein gp120 distri..:

Hart, T K ; Klinkner, A M ; Ventre, J.
Journal of Histochemistry & Cytochemistry. 41 (1993) 2 - p. 265-271 , 1993

Link: https://doi.org/10.1177/..

8

Binding of soluble CD4 proteins to human immunodeficiency v..:

Hart, T K ; Kirsh, R ; Ellens, H...
Proceedings of the National Academy of Sciences. 88 (1991) 6 - p. 2189-2193 , 1991

Link: https://doi.org/10.1073/..

9

Density gradient separation of two populations of lysosomes..:

Oliver, C ; Dromy, R ; Hart, T K
Journal of Histochemistry & Cytochemistry. 37 (1989) 11 - p. 1645-1652 , 1989

Link: https://doi.org/10.1177/..

10

Targeting MDMX and PKCδ to improve current uveal melanoma t..:

Heijkants, R. C. ; Nieveen, M. ; Hart, K. C.'t..
Oncogenesis. 7 (2018) 3 - p. , 2018

Link: https://doi.org/10.1038/..

11

Preclinical efficacy and safety of pascolizumab (SB 240683)..:

HART, T K ; BLACKBURN, M N ; BRIGHAM-BURKE, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906490. , 2002

Link: http://www.ncbi.nlm.nih...

12

Search for Charmless [Formula presented] Decays:

Godang, R. (R.) ; Shipsey, I.P.J. (I. P.J.) ; Bonvicini, G. (G.)...
https://ir.library.carleton.ca/pub/17140. , 2002

Link: https://ir.library.carle..

13

A single amino acid change in the cytoplasmic domain of the..:

LaBranche, C C ; Sauter, M M ; Haggarty, B S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC189351. , 1995

Link: http://www.ncbi.nlm.nih...

14

Biological, molecular, and structural analysis of a cytopat..:

LaBranche, C C ; Sauter, M M ; Haggarty, B S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC236951. , 1994

Link: http://www.ncbi.nlm.nih...

15

Biological, molecular, and structural analysis of a cytopat..:

LaBranche, C C ; Sauter, M M ; Haggarty, B S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC237221. , 1994

Link: http://www.ncbi.nlm.nih...